FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

6 letters match. Newest first.

  1. Molluscumaway LLC

    FDA warned Molluscumaway LLC that its molluscum patches, ointment, and body wash are unapproved new drugs.

    High risk
  2. MolluscumRx, Inc.

    FDA told MolluscumRx, Inc. of Orlando, Florida that its molluscum lotion and soap are unapproved new drugs sold with unsupported cure claims.

    High risk
  3. Nature’s Innovation, Inc.

    FDA warned Nature’s Innovation over unapproved drugs marketed for molluscum and shingles, including a kit for children.

    High risk
  4. Thrasio, LLC D/B/A ZymaDerm

    FDA warned Thrasio/ZymaDerm that its ZymaDerm for Molluscum is an unapproved new drug marketed without FDA approval.

    High risk
  5. Walmart, Inc

    FDA warned Walmart over selling Naturasil Molluscum Treatment Kit, an unapproved new drug for molluscum.

    High risk
  6. Amazon.com, Inc

    FDA warned Amazon that it sold four unapproved drugs claiming to treat molluscum contagiosum, including products marketed for children.

    High risk